New hope for leukemia patients who have run out of options
NCT ID NCT05657652
Summary
This study is testing a new combination of three drugs (venetoclax, cladribine, and cytarabine) for adults with a specific type of acute lymphoblastic leukemia (ALL) that has returned or not responded to previous treatments. The goal is to see if this drug combo can effectively control the cancer and is safe for patients. Researchers will measure how many patients respond to treatment and how long they live without the cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.